BioDuro Acquires Tumor Biobanking, Modeling Firm Molecular Response
Through the deal, BioDuro has acquired Molecular Response's translational oncology research platform and its biobank of viable tumor specimens.
Crown Bio Buys Molecular Response's PDX Business
Crown is acquiring Molecular Response's existing PDX models and 8,000 viable human tumors for model development.
Boston Strategics, Molecular Response Ink Deal to Improve Oncology Rx Trial Success
NEW YORK (GenomeWeb) – Therapeutic research firm Boston Strategics and molecular diagnostic services shop Molecular Response have agreed to design and manage drug development programs together with the aim of identifying subpopulations of best responders to treatments and improving their probabil
Molecular Response, Transparent Ink Pact to Market 3D Cell Culture System
NEW YORK (GenomeWeb News) – Transparent and Molecular Response today announced the extension of validation studies and the execution of a long-term collaboration agreement.
In Brief This Week: Gen-Probe, Pacific Biosciences; OpGen; Danaher; CEPMED; Bioke; Molecular Response; Biodesix
NEW YORK (GenomeWeb News) – Gen-Probe disclosed in its annual 2011 earnings document that it has lost almost $41 million in its investment in Pacific Biosciences as of the end of 2011.
Nov 9, 2010
People in the News: Nov 9, 2010
Nov 4, 2010